4.8 Article

Signal-On Electrochemical Detection for Drug-Resistant Hepatitis B Virus Mutants through Three-Way Junction Transduction and Exonuclease III-Assisted Catalyzed Hairpin Assembly

Journal

ANALYTICAL CHEMISTRY
Volume 94, Issue 2, Pages 600-605

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.1c03451

Keywords

-

Funding

  1. National Natural Science Foundation of China [21874129, 22174137]
  2. Fundamental Research Funds for the Central Universities [2412020QD007, JGPY201802, 2412020ZD006, 2412019QD008]
  3. Human Resources and Social Security Department of Jilin Province
  4. Key Laboratory of Nanobiosensing and Nanobioanalysis at Universities of Jilin Province
  5. Analysis and Testing Center of Northeast Normal University
  6. 111 Project (China) [B18012]
  7. Jilin Provincial Department of Education (China)
  8. Key Research and Development Projects of Jilin Scientific and Technological Development Program [202102041266YY]

Ask authors/readers for more resources

This study proposes an electrochemical signal-on strategy for highly sensitive detection of HBV drug-resistant mutations, providing a new approach for developing cost-effective diagnostic methods. By utilizing LAMP isothermal amplification technique, the method shows potential for wide application in clinical HBV diagnosis and detection of other disease genes.
The present detection method for hepatitis B virus (HBV) drug-resistant mutation has a high misdiagnosis rate and usually needs to meet stringent requirements for technology and equipment, leading to complex and time-consuming manipulation and drawback of high costs. Herein, with the purpose of developing cost-effective, highly efficient, and handy diagnosis for HBV drug-resistant mutants, we propose an electrochemical signal-on strategy through the three-way junction (3WJ) transduction and exonuclease III (Exo III)-assisted catalyzed hairpin assembly (CHA). To achieve single-copy gene detection, loop-mediated nucleic acid isothermal amplification (LAMP), one of the highly promising and compatible techniques to revolutionize point-of-care genetic detection, is first adopted for amplification. The rtN236T mutation, an error encoded by codon 236 of the reverse transcriptase region of HBV DNA, was employed as the model gene target. Under the optimized conditions, it allows end-point transduction from HBV drug-resistant mutants-genomic information to electrochemical signals with ultrahigh sensitivity, specificity, and signal-to-noise ratio, showing the lowest detection concentration down to 2 copies/mu L. Such a method provides a possibly new principle for ideal in vitro diagnosis, supporting the construction of a clinic HBV diagnosis platform with high accuracy and generalization. Moreover, it is not restricted by specific nucleic acid sequences but can be applied to the detection of various disease genes, laying the foundation for multiple detection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available